Skip to Content
Merck
CN

DART®-MS Analysis of Methamphetamine and Amphetamine in Urine Using BioSPME

DART®-MS Analysis of Methamphetamine and Amphetamine in Urine Using BioSPME application for SPME

Materials

related product

Product No.
Description
Pricing

(±)-Amphetamine-d5 (deuterium label on ring) solution

100 μg/mL in methanol, ampule of 1 mL, certified reference material, Cerilliant®

(±)-Amphetamine solution

1.0 mg/mL in methanol, ampule of 1 mL, certified reference material, Cerilliant®

(±)-Methamphetamine-D5 solution

100 μg/mL in methanol, ampule of 1 mL, certified reference material, Cerilliant®

(±)-Methamphetamine solution

1.0 mg/mL in methanol, ampule of 1 mL, certified reference material, Cerilliant®

CONDITIONS

SPME fiber

BioSPME (SPME LC) Mixed Mode fiber

extraction

10 min with 1 mL sample

desorption process

Direct MS

detector

MS, Full scan 100-500 amu

Description

Analysis Note

BioSPME was used to determine the presence of methamphetamine and amphetamine in urine samples. Initial screening results can be obtained in less than 60 seconds by analyzing the extracted urine samples on a DART-MS system. By employing a fast and accurate screening method, the number of samples that require chiral separation can be reduced and laboratories can increase throughput and decrease costs associated with their drug screening programs.

Legal Information

DART is a registered trademark of JEOL USA, Inc.